Article
Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain.
Pain physician - 1 Jan 2013
Ehret Georg B, Daali Youssef, Chabert Jocelyne, Rebsamen Michela, Wolff Adriana, Forster Alain, Moursli Fouzia, Fritschy Daniel, Rossier Michel F, Piguet Valérie, Dayer Pierre, Gex-Fabry Marianne, Desmeules Jules A
Abstract excerpt
BACKGROUND: There is some evidence that dextromethorphan (DM) is effective as a pre-emptive analgesic agent. DM is mainly metabolized to dextrorphan (DOR) by CYP2D6 whose activity can be inhibited by pharmacologic intervention. OBJECTIVES: To investigate the efficacy of DM as a pre-emptive analge...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
